Ameritas Investment Partners’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-11,408
| Closed | -$449K | – | 3152 |
|
|
2023
Q2 | $449K | Buy |
11,408
+641
| +6% | +$22.6K | 0.02% | 802 |
|
|
2023
Q1 | $262K | Hold |
10,767
| – | – | 0.01% | 963 |
|
|
2022
Q4 | $220K | Buy |
10,767
+1,875
| +21% | +$40K | 0.01% | 1085 |
|
|
2022
Q3 | $159K | Hold |
8,892
| – | – | 0.01% | 1185 |
|
|
2022
Q2 | $85K | Hold |
8,892
| – | – | ﹤0.01% | 1633 |
|
|
2022
Q1 | $150K | Hold |
8,892
| – | – | 0.01% | 1372 |
|
|
2021
Q4 | $149K | Buy |
8,892
+891
| +11% | +$14.6K | 0.01% | 1432 |
|
|
2021
Q3 | $130K | Buy |
8,001
+1,156
| +17% | +$12.6K | ﹤0.01% | 1526 |
|
|
2021
Q2 | $43K | Hold |
6,845
| – | – | ﹤0.01% | 2292 |
|
|
2021
Q1 | $42K | Hold |
6,845
| – | – | ﹤0.01% | 2194 |
|
|
2020
Q4 | $47K | Hold |
6,845
| – | – | ﹤0.01% | 2029 |
|
|
2020
Q3 | $39K | Buy |
6,845
+2,860
| +72% | +$13.6K | ﹤0.01% | 2001 |
|
|
2020
Q2 | $20K | Buy |
+3,985
| New | +$16.6K | ﹤0.01% | 2353 |
|
|
2017
Q2 | – | Sell |
-2,634
| Closed | -$10K | – | 3070 |
|
|
2017
Q1 | $10K | Buy |
+2,634
| New | +$11.1K | ﹤0.01% | 2706 |
|
Ameritas Investment Partners's ISEE Position: Q3 2023 in Review
Ameritas Investment Partners sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 11,408 shares — an estimated $449K sold.
Ameritas Investment Partners first reported a position in ISEE in Q1 2017 and held it in 14 quarters. The position peaked at $449K in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Ameritas Investment Partners reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Ameritas Investment Partners sold 11,408 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $449K.
- Ameritas Investment Partners first reported a position in IVERIC bio, Inc. Common Stock in Q1 2017 and held it in 14 quarters.
- Ameritas Investment Partners's IVERIC bio, Inc. Common Stock position peaked at $449K in Q2 2023.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Ameritas Investment Partners's 13F filing for Q3 2023, filed 13 Nov 2023.